A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Clinical trial NCT01371838 · COMPLETED

Trial details

NCT number: NCT01371838
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Community-Acquired Bacterial Pneumonia Lung Infection of Individual Not Recently Hospitalized

Start date: 2011-12-01
Primary completion: 2013-05-01
Enrollment: 848

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.